Literature DB >> 19685888

Calcitriol derivatives with two different side chains at C-20. V. Potent inhibitors of mammary carcinogenesis and inducers of leukemia differentiation.

Hubert Maehr1, Hong Jin Lee, Bradford Perry, Nanjoo Suh, Milan R Uskokovic.   

Abstract

Calcitriol is implicated in many cellular functions including cellular growth and differentiation, thus explaining its antitumor effects. It was shown that gemini, the calcitriol derivative containing two side chain at C20, is also active in gene transcription with enhanced antitumor activity. We have now further optimized both the A-ring and the two side chains. The chemical structures of the resulting 18 geminis were correlated with biological activities. Those containing the 1alpha-fluoro A-ring are the least active. Those featuring 23-yne and 23(E) side-chains are generally more active in human breast cancer cell growth inhibition and human leukemia cell differentiation induction than their 23(Z) counterparts. On the basis of these evaluations, we selected as lead compound a 20(R) gemini, related to calcitriol in terms of it is A-ring, where one side chain was modified by introduction of a 23-yne function and replacement of the geminal methyl groups with trifluoromethyl groups, the other created by extension of C21 with a 3-hydroxy-3-trideuteromethyl-4,4,4-trideutero-butyl moiety.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19685888      PMCID: PMC2767326          DOI: 10.1021/jm900780q

Source DB:  PubMed          Journal:  J Med Chem        ISSN: 0022-2623            Impact factor:   7.446


  26 in total

1.  Mechanism of action of superactive vitamin D analogs through regulated receptor degradation.

Authors:  T Jääskeläinen; S Ryhänen; A Mahonen; H F DeLuca; P H Mäenpää
Journal:  J Cell Biochem       Date:  2000-01       Impact factor: 4.429

2.  Structural investigation of the ligand binding domain of the zebrafish VDR in complexes with 1alpha,25(OH)2D3 and Gemini: purification, crystallization and preliminary X-ray diffraction analysis.

Authors:  Fabrice Ciesielski; Natacha Rochel; Andre Mitschler; Alexander Kouzmenko; Dino Moras
Journal:  J Steroid Biochem Mol Biol       Date:  2004-05       Impact factor: 4.292

3.  Calcitriol derivatives with two different side chains at C-20 III. An epimeric pair of the gemini family with unprecedented antiproliferative effects on tumor cells and renin mRNA expression inhibition.

Authors:  Hubert Maehr; Milan Uskokovic; Luciano Adorini; Giuseppe Penna; Roberto Mariani; Paola Panina; Nadia Passini; Elisa Bono; Silvia Perego; Mauro Biffi; Michael Holick; Catherine Spina; Nanjoo Suh
Journal:  J Steroid Biochem Mol Biol       Date:  2007-01-24       Impact factor: 4.292

4.  Differential interaction of 1alpha,25-dihydroxyvitamin D3 analogues and their 20-epi homologues with the vitamin D receptor.

Authors:  Y Y Liu; E D Collins; A W Norman; S Peleg
Journal:  J Biol Chem       Date:  1997-02-07       Impact factor: 5.157

5.  Gene expression profiling changes induced by a novel Gemini Vitamin D derivative during the progression of breast cancer.

Authors:  Hong Jin Lee; Hao Liu; Catherine Goodman; Yan Ji; Hubert Maehr; Milan Uskokovic; Daniel Notterman; Michael Reiss; Nanjoo Suh
Journal:  Biochem Pharmacol       Date:  2006-05-05       Impact factor: 5.858

6.  Adaptability of the Vitamin D nuclear receptor to the synthetic ligand Gemini: remodelling the LBP with one side chain rotation.

Authors:  Fabrice Ciesielski; Natacha Rochel; Dino Moras
Journal:  J Steroid Biochem Mol Biol       Date:  2007-01-10       Impact factor: 4.292

7.  Efficient Fluorination with Tetrabutylammonium Dihydrogen Trifluoride in a Novel Approach toward 1-alpha-Fluoro-25-hydroxy-vitamin D(3) Analogues.

Authors:  Pierre Barbier; Peter Mohr; Marc Muller; Raffaello Masciadri
Journal:  J Org Chem       Date:  1998-10-02       Impact factor: 4.354

8.  Efficient synthesis of the A-ring phosphine oxide building block useful for 1 alpha,25-dihydroxy vitamin D(3) and analogues.

Authors:  Andrzej R Daniewski; Lisa M Garofalo; Stanley D Hutchings; Marek M Kabat; Wen Liu; Masami Okabe; Roumen Radinov; George P Yiannikouros
Journal:  J Org Chem       Date:  2002-03-08       Impact factor: 4.354

9.  Differential regulation of heterodimerization by 1alpha,25-dihydroxyvitamin D(3) and its 20-epi analog.

Authors:  Y Y Liu; C Nguyen; S A Ali Gardezi; I Schnirer; S Peleg; S Ali Gradezi
Journal:  Steroids       Date:  2001 Mar-May       Impact factor: 2.668

10.  Calcitriol derivatives with two different side chains at C-20. 24-hydroxy derivatives as metabolic products and molecular probes for VDR exploration.

Authors:  Hubert Maehr; Milan R Uskokovic; G Satyanarayana Reddy; Luciano Adorini
Journal:  J Steroid Biochem Mol Biol       Date:  2004-05       Impact factor: 4.292

View more
  13 in total

1.  Vitamin D compounds inhibit cancer stem-like cells and induce differentiation in triple negative breast cancer.

Authors:  Naing Lin Shan; Joseph Wahler; Hong Jin Lee; Min Ji Bak; Soumyasri Das Gupta; Hubert Maehr; Nanjoo Suh
Journal:  J Steroid Biochem Mol Biol       Date:  2016-12-05       Impact factor: 4.292

2.  Structure-function study of gemini derivatives with two different side chains at C-20, Gemini-0072 and Gemini-0097.

Authors:  Tiphaine Huet; Hubert Maehr; Hong Jin Lee; Milan R Uskokovic; Nanjoo Suh; Dino Moras; Natacha Rochel
Journal:  Medchemcomm       Date:  2011       Impact factor: 3.597

3.  A novel Gemini vitamin D analog represses the expression of a stem cell marker CD44 in breast cancer.

Authors:  Jae Young So; Hong Jin Lee; Amanda K Smolarek; Shiby Paul; Chung-Xiou Wang; Hubert Maehr; Milan Uskokovic; Xi Zheng; Allan H Conney; Li Cai; Fang Liu; Nanjoo Suh
Journal:  Mol Pharmacol       Date:  2010-11-29       Impact factor: 4.436

4.  Oral administration of a gemini vitamin D analog, a synthetic triterpenoid and the combination prevents mammary tumorigenesis driven by ErbB2 overexpression.

Authors:  Jae Young So; Joseph E Wahler; Taesook Yoon; Amanda K Smolarek; Yong Lin; Weichung Joe Shih; Hubert Maehr; Milan Uskokovic; Karen T Liby; Michael B Sporn; Nanjoo Suh
Journal:  Cancer Prev Res (Phila)       Date:  2013-07-15

5.  Vitamin D compounds reduce mammosphere formation and decrease expression of putative stem cell markers in breast cancer.

Authors:  Joseph Wahler; Jae Young So; Larry C Cheng; Hubert Maehr; Milan Uskokovic; Nanjoo Suh
Journal:  J Steroid Biochem Mol Biol       Date:  2014-10-31       Impact factor: 4.292

6.  HES1-mediated inhibition of Notch1 signaling by a Gemini vitamin D analog leads to decreased CD44(+)/CD24(-/low) tumor-initiating subpopulation in basal-like breast cancer.

Authors:  Jae Young So; Joseph Wahler; Soumyasri Das Gupta; David M Salerno; Hubert Maehr; Milan Uskokovic; Nanjoo Suh
Journal:  J Steroid Biochem Mol Biol       Date:  2014-12-23       Impact factor: 4.292

7.  Structural analysis and biological activities of BXL0124, a gemini analog of vitamin D.

Authors:  Anna Y Belorusova; Nanjoo Suh; Hong Jin Lee; Jae Young So; Hubert Maehr; Natacha Rochel
Journal:  J Steroid Biochem Mol Biol       Date:  2016-09-17       Impact factor: 4.292

8.  Inhibition of the transition of ductal carcinoma in situ to invasive ductal carcinoma by a Gemini vitamin D analog.

Authors:  Joseph Wahler; Jae Young So; Yeoun Chan Kim; Fang Liu; Hubert Maehr; Milan Uskokovic; Nanjoo Suh
Journal:  Cancer Prev Res (Phila)       Date:  2014-04-01

9.  Targeting CD44-STAT3 signaling by Gemini vitamin D analog leads to inhibition of invasion in basal-like breast cancer.

Authors:  Jae Young So; Amanda K Smolarek; David M Salerno; Hubert Maehr; Milan Uskokovic; Fang Liu; Nanjoo Suh
Journal:  PLoS One       Date:  2013-01-11       Impact factor: 3.240

10.  Differentiation therapy of acute myeloid leukemia.

Authors:  Elzbieta Gocek; Ewa Marcinkowska
Journal:  Cancers (Basel)       Date:  2011-05-16       Impact factor: 6.639

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.